Galderma's Mirvaso receives European approval for treatment of Rosacea

The European Commission (EC) has granted marketing authorisation in Europe for Switzerland-based pharmaceutical firm Galderma's Mirvaso (brimonidine) 3mg/g gel for the treatment of facial redness, also known as rosacea.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news